| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥594.7B | ¥570.3B | +4.3% |
| Operating Income | ¥19.6B | ¥29.6B | -33.8% |
| Ordinary Income | ¥19.1B | ¥30.1B | -36.4% |
| Net Income | ¥96.9B | ¥28.1B | +244.8% |
| ROE | 22.7% | 9.0% | - |
FY2025 results: Revenue 594.7B yen (YoY +4.3%), Operating Income 19.6B yen (YoY -33.8%), Ordinary Income 19.1B yen (YoY -36.4%), Net Income 96.9B yen (YoY +244.8%). The company achieved modest top-line growth but experienced significant deterioration in operating profitability. Operating margin declined to 3.3% from 5.2% YoY, declining 1.9pt. Net income surged 244.8% driven predominantly by extraordinary gains of 123.8B yen, primarily from asset sales, rather than operational improvements. The divergence between operating income decline of 33.8% and net income surge of 244.8% highlights the non-recurring nature of profitability. Gross profit margin stood at 18.9%, declining 1.1pt from prior year, while SG&A expense ratio increased 0.6pt to 15.6%, resulting in compressed operating margins. Total assets expanded to 841.6B yen from 727.1B yen, with equity increasing substantially to 426.7B yen from 310.7B yen, driven by retained earnings accumulation from the extraordinary income boost.
Revenue increased 24.4B yen to 594.7B yen, representing 4.3% YoY growth. Foods segment revenue grew 23.9B yen to 422.1B yen (+6.0% YoY), while Oil Chemicals segment revenue increased 2.2B yen to 170.6B yen (+1.3% YoY). The Foods segment, comprising margarine, shortening, lard, powdered oils, whipped cream and other edible processed fats, drove the majority of revenue expansion. Oil Chemicals segment, which includes fatty acids, glycerin, industrial soaps, textile treatment agents and surfactants, contributed modest growth. Other segment revenue declined 0.1B yen to 4.8B yen, reflecting reduced real estate rental and raw material oil activities.
Gross profit declined 1.9B yen to 112.7B yen despite revenue growth, with gross margin compressing to 18.9% from 20.0%. This 1.1pt margin erosion indicates raw material cost increases and pricing challenges outpaced revenue growth. Cost of goods sold increased 26.2B yen to 482.1B yen (+5.7%), growing faster than the 4.3% revenue increase. SG&A expenses increased 3.8B yen to 93.0B yen (+4.3%), in line with revenue growth, resulting in SG&A ratio increasing 0.6pt to 15.6% from 15.0%.
Operating income declined 10.0B yen to 19.6B yen, a 33.8% decrease. Foods segment operating income fell 4.8B yen to 14.4B yen (-25.0%), while Oil Chemicals segment operating income declined 5.8B yen to 4.4B yen (-56.8%), indicating severe margin compression across both core segments. Other segment operating income improved 0.6B yen to 0.7B yen. The combination of gross margin erosion and elevated SG&A compressed operating margins to 3.3% from 5.2%, declining 1.9pt YoY.
Non-operating income and expenses resulted in a net loss of 0.4B yen, with non-operating expenses of 6.2B yen slightly exceeding non-operating income of 5.8B yen. Interest expenses of 4.9B yen represented a significant cost, partially offset by dividend income of 2.6B yen and interest income of 0.7B yen. Ordinary income declined 11.0B yen to 19.1B yen (-36.4%), broadly consistent with operating income deterioration.
Extraordinary gains of 123.8B yen drove a substantial divergence between ordinary and net income. Extraordinary income consisted primarily of gains from asset disposals, while extraordinary losses of 4.2B yen were minimal. Income before tax reached 138.8B yen, up 109.7B yen from 29.1B yen prior year. After tax expenses of 42.6B yen, net income reached 96.9B yen, representing a 244.8% increase from 28.1B yen. However, this net income surge is attributable entirely to non-recurring extraordinary gains rather than operational improvement.
This represents a revenue up, profit down pattern at the operating level, masked at the net income level by extraordinary gains. The underlying operating deterioration warrants concern, as sustainable profitability has weakened significantly despite modest revenue growth.
Foods segment generated revenue of 422.1B yen (+6.0% YoY) and operating income of 14.4B yen (-25.0% YoY), with operating margin of 3.4%, declining 1.3pt from 4.8% prior year. This segment represents 70.9% of total revenue and 73.5% of total operating income, establishing it as the core business. The segment includes margarine, shortening, lard, powdered oils, whipped cream and other edible processed fats. Despite revenue growth, operating margin compression indicates raw material cost pressures and competitive pricing challenges in the food processing market.
Oil Chemicals segment generated revenue of 170.6B yen (+1.3% YoY) and operating income of 4.4B yen (-56.8% YoY), with operating margin of 2.6%, declining 3.4pt from 6.1% prior year. This segment represents 28.7% of total revenue and 22.4% of total operating income. The segment encompasses fatty acids, glycerin, industrial soaps, textile treatment agents, defoaming agents, cosmetic raw materials, heavy metal collectors and various surfactants. The Oil Chemicals segment experienced more severe margin deterioration than Foods, indicating significant cost or pricing pressures in industrial applications.
Other segment generated revenue of 4.8B yen and operating income of 0.7B yen, contributing minimal amounts to overall results. This segment includes real estate rental and raw material oils not classified in the primary segments.
The Foods segment exhibits marginally higher operating margin at 3.4% versus Oil Chemicals at 2.6%, though both segments operate at notably low margins compared to typical food and chemical manufacturing industries. Segment asset allocation shows Foods at 516.5B yen and Oil Chemicals at 258.3B yen, with both segments experiencing asset base expansion. The core Foods business maintained revenue momentum but requires margin restoration, while Oil Chemicals faces more acute profitability challenges requiring operational review.
[Profitability] ROE reached 22.7%, substantially elevated from prior year, driven primarily by extraordinary income boosting net income rather than operational improvements. Operating margin declined to 3.3% from 5.2%, down 1.9pt YoY, indicating deteriorating operational efficiency. Gross margin compressed to 18.9% from 20.0%, down 1.1pt, reflecting unfavorable cost dynamics. EBIT margin of 3.3% falls below typical industry benchmarks of 5% or higher, warranting concern. Net profit margin reached 16.3% versus 4.9% prior year, but this improvement is attributable to non-recurring extraordinary gains rather than sustainable profitability. ROIC stood at 3.3%, indicating insufficient returns on invested capital and highlighting capital efficiency challenges. [Cash Quality] Cash and cash equivalents increased to 96.7B yen from 70.7B yen (+36.8%), providing improved liquidity. Short-term debt coverage improved with cash covering 2.0x of short-term borrowings of 48.4B yen. Operating cash flow of 23.5B yen represents only 0.24x of net income, indicating weak cash conversion and raising earnings quality concerns. Cash conversion ratio of 0.64 (operating CF to EBITDA) suggests operating activities generate cash below EBITDA levels, warranting monitoring. [Investment Efficiency] Asset turnover declined to 0.71x from 0.78x, reflecting reduced revenue generation efficiency per yen of assets. Days sales outstanding reached 94 days, indicating extended collection periods and potential working capital inefficiency. Capital expenditure of 48.2B yen represents 2.85x depreciation of 16.9B yen, demonstrating aggressive investment relative to asset replacement needs. [Financial Health] Equity ratio strengthened to 50.7% from 42.7%, improving 8.0pt and reflecting enhanced financial stability. Current ratio stood at 157.4%, indicating adequate short-term liquidity with current assets of 376.8B yen covering current liabilities of 239.4B yen. Debt-to-equity ratio improved to 0.19 from 0.38, with interest-bearing debt declining to 80.7B yen. However, short-term debt ratio of 59.9% indicates elevated dependence on short-term funding, warranting attention to refinancing risk.
Operating cash flow of 23.5B yen declined 28.5% YoY, representing only 0.24x of net income and indicating substantial divergence between accounting profits and cash generation. The weak cash conversion reflects working capital expansion, with accounts receivable increasing and inventory levels rising. Investing cash flow of 53.1B yen was positive, driven primarily by proceeds from asset sales rather than typical investing outflows. Capital expenditures of 48.2B yen represent ongoing investment at 2.85x depreciation levels, indicating growth or capacity expansion initiatives. The substantial positive investing cash flow, unusual for manufacturing operations, reflects the non-recurring asset disposal gains recorded in extraordinary income. Free cash flow of 76.6B yen appears robust but incorporates the one-time asset sale proceeds, thus overstating sustainable cash generation capacity. Financing cash flow of negative 52.2B yen reflects debt reduction and shareholder returns, with short-term borrowings declining 20.0B yen to 48.4B yen. Interest-bearing debt decreased from 105.8B yen to 80.7B yen, improving the debt profile. Overall cash and deposits increased 26.0B yen to 96.7B yen, providing enhanced liquidity cushion. The cash flow profile indicates reliance on asset monetization rather than operating cash generation, with operating CF quality remaining a concern for sustainable operations and investment funding.
Ordinary income of 19.1B yen versus operating income of 19.6B yen indicates a net non-operating expense of approximately 0.5B yen. Non-operating expenses of 6.2B yen primarily comprised interest expenses of 4.9B yen and other non-operating expenses of 0.6B yen, offset by non-operating income of 5.8B yen including dividend income of 2.6B yen, interest income of 0.7B yen and other income of 1.6B yen. Non-operating items represent approximately 1.0% of revenue, a relatively modest proportion. Extraordinary income of 123.8B yen versus extraordinary losses of 4.2B yen resulted in net extraordinary gains of 119.6B yen, representing 20.1% of revenue and constituting the primary driver of net income expansion. This substantial extraordinary income, primarily from gains on asset sales of 0.2B yen disclosed with additional unspecified gains implied, represents non-recurring factors that will not repeat in future periods. Operating cash flow of 23.5B yen fell significantly below net income of 96.9B yen, with the ratio of 0.24x indicating poor earnings quality and cash conversion. This divergence stems from the extraordinary gains being non-cash or non-operating in nature, combined with working capital expansion absorbing operating cash. Days sales outstanding of 94 days and inventory levels indicate working capital management requires improvement to enhance cash conversion. The earnings quality assessment highlights that reported net income substantially overstates sustainable earnings capacity, with core operating profitability declining and cash generation weak relative to accounting profits.
Full-year guidance calls for revenue of 622.0B yen (+4.6% YoY), operating income of 25.4B yen (+29.6% YoY), ordinary income of 23.0B yen (+20.2% YoY), and net income of 14.9B yen. Current period results show revenue at 594.7B yen representing 95.6% progress, operating income at 19.6B yen representing 77.2% progress, ordinary income at 19.1B yen representing 83.0% progress, and net income at 96.9B yen representing 650.3% progress against guidance. The substantial net income overperformance stems entirely from extraordinary gains of 123.8B yen not contemplated in original guidance. Operating income progress of 77.2% trails the expected run rate, suggesting the operating margin improvement embedded in guidance requires significant fourth quarter performance or has not been achieved. For full-year guidance achievement, the company requires operating income of 5.8B yen in the remaining period, implying operating margin recovery in final reporting. Given the actual operating margin deterioration experienced at 3.3% versus prior year 5.2%, the guidance operating margin target appears optimistic absent substantive cost reduction or pricing actions. Revenue guidance progress of 95.6% suggests modest remaining growth, consistent with the current 4.3% YoY trend. The guidance implies operating income margin of 4.1% for the full year versus 3.3% achieved, requiring margin expansion. Forecast EPS of 146.06 yen and dividend forecast of 70.00 yen indicate planned shareholder returns, with dividend representing a payout ratio of 48.0% against forecast net income. The guidance update suggests management expects operating performance recovery not yet evident in current results, with extraordinary gains masking underlying operational challenges.
Annual dividend per share stands at 70.00 yen for the forecast period, compared to 60.00 yen in the current period, representing a 16.7% dividend increase. The dividend payout ratio against current period net income of 943.10 yen per share is 6.4%, appearing conservative. However, this calculation is distorted by the extraordinary gains inflating net income; adjusting for sustainable earnings would show a materially higher payout ratio. Against forecast EPS of 146.06 yen, the forecast dividend of 70.00 yen represents a 47.9% payout ratio, more reflective of normalized earnings capacity. The company reported payout ratio of 21.7% in financial data, suggesting alternative calculation methodology. No share buyback activity occurred in the period, with share repurchases of 0.0B yen reported. Total return to shareholders consists of dividends only, with total return ratio equivalent to the dividend payout ratio. Free cash flow of 76.6B yen provides 12.4x coverage of dividend payments, though this coverage is inflated by non-recurring asset sale proceeds contributing to investing cash inflows. Operating cash flow of 23.5B yen provides 3.8x coverage of dividends, more representative of sustainable coverage from operating activities. The dividend increase signals confidence in normalized earnings recovery, though actual operating cash generation requires improvement to support sustainable shareholder returns alongside capital investment needs. Shares outstanding of 10,307 thousand with treasury shares of 106 thousand and average shares of 10,196 thousand remained stable, with no material buyback activity impacting share count.
Profitability deterioration risk: Operating margin declined 1.9pt to 3.3%, with gross margin compressing 1.1pt to 18.9% and both Foods and Oil Chemicals segments experiencing significant margin erosion. Foods segment margin fell 1.3pt to 3.4% while Oil Chemicals margin declined 3.4pt to 2.6%. Persistent raw material cost inflation without corresponding pricing power could further compress margins below sustainable levels. The low absolute operating margin of 3.3% provides minimal buffer against further cost pressures or volume declines.
Cash conversion risk: Operating cash flow of 23.5B yen represents only 0.24x of net income, indicating severe earnings quality concerns. Days sales outstanding of 94 days and working capital expansion absorb operating cash generation. Cash conversion ratio of 0.64 (operating CF to EBITDA) indicates structural challenges in converting earnings to cash. Continued weak cash conversion would constrain self-funding capacity for capital expenditure of 48.2B yen annually and dividend obligations, potentially requiring external financing or asset monetization.
Refinancing and liquidity risk: Short-term debt ratio of 59.9% indicates elevated dependence on short-term borrowings, creating refinancing exposure if credit conditions tighten. While current ratio of 157.4% and cash coverage of short-term debt at 2.0x provide near-term cushion, the structural reliance on short-term funding warrants monitoring. Interest-bearing debt of 80.7B yen includes short-term borrowings of 48.4B yen requiring regular refinancing, exposing the company to interest rate increases and credit availability fluctuations.
[Industry Position] (Reference - Proprietary Analysis) Operating margin of 3.3% positions below typical food manufacturing and oleochemical industry benchmarks of 5-8%, indicating below-average operational efficiency. Gross margin of 18.9% falls short of food processing industry medians of 25-40%, reflecting product mix skewed toward lower-margin commodity products or insufficient pricing power. ROE of 22.7% appears elevated but is distorted by non-recurring extraordinary gains; normalized ROE based on operating earnings would approximate 6-8%, closer to or below industry median ranges of 8-12% for food manufacturers. Equity ratio of 50.7% aligns with industry medians of 45-55%, indicating comparable financial stability. Debt-to-equity ratio of 0.19 positions favorably versus industry medians of 0.3-0.5, reflecting conservative leverage. Operating cash flow to sales ratio of 4.0% (23.5B yen / 594.7B yen) falls below industry medians of 6-10%, highlighting cash generation weakness. Days sales outstanding of 94 days exceeds food industry medians of 60-75 days, indicating extended collection cycles requiring improvement. Capital intensity with CapEx at 2.85x depreciation suggests above-average investment requirements relative to maintenance needs. The company operates as a mid-tier player in food fats and oils plus oleochemicals, with competitive positioning challenged by margin pressures and working capital inefficiency. Market position benefits from established customer relationships in food processing and industrial applications, though commodity-like product characteristics limit differentiation and pricing power.
(Industry: Food Manufacturing and Oleochemicals, Comparison: Historical company trends over 5 periods, Source: Proprietary analysis)
Net income expansion of 244.8% driven by extraordinary asset sale gains of 123.8B yen masks underlying operating deterioration, with operating income declining 33.8% and operating margin compressing 1.9pt to 3.3%. This divergence indicates non-recurring factors inflating reported profitability, with sustainable earnings capacity materially weaker than headline results suggest. Investors should focus on core operating metrics rather than net income for valuation and trend assessment.
Operating cash flow of 23.5B yen representing only 0.24x of net income highlights severe earnings quality concerns and weak cash conversion. Combined with elevated days sales outstanding of 94 days and working capital expansion, the cash generation profile warrants caution. Sustained weak operating cash flow relative to capital expenditure requirements of 48.2B yen and dividend obligations may necessitate external financing or further asset monetization, constraining financial flexibility.
Balance sheet strengthening with equity ratio improving to 50.7% and cash increasing to 96.7B yen provides enhanced financial stability, though this primarily reflects the extraordinary income retention. Debt reduction with interest-bearing debt declining to 80.7B yen and improved debt-to-equity ratio of 0.19 enhance credit profile. However, short-term debt ratio of 59.9% maintains refinancing exposure requiring monitoring. The improved financial position provides capacity to navigate near-term operational challenges, though restoration of operating margin and cash generation remains imperative for sustained value creation.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.